Death	death	O	DISEASE	OTHERS	I
from	from	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
in	in	O	O	O	O
gestational	gestational	O	DISEASE	OTHERS	I
trophoblastic	trophoblastic	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Multiple	multiple	O	O	O	O
cytotoxic	cytotoxic	O	O	O	O
drug	drug	O	O	O	O
administration	administration	O	O	O	O
is	is	O	O	O	O
the	the	O	O	O	O
generally	generally	O	O	O	O
accepted	accepted	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
high-risk	high-risk	O	O	O	O
stage	stage	O	O	O	O
of	of	O	O	O	O
choriocarcinoma	choriocarcinoma	O	O	OTHERS	I
.	.	O	O	O	O

Based	based	O	O	O	O
on	on	O	O	O	O
this	this	O	O	O	O
principle	principle	O	O	O	O
a	a	O	O	O	O
27-year	27-year	O	O	O	O
old	old	O	O	O	O
woman	woman	O	O	O	O
,	,	O	O	O	O
classified	classified	O	O	O	O
as	as	O	O	O	O
being	being	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
high-risk	high-risk	O	O	O	O
group	group	O	O	O	O
(	(	O	O	O	O
Goldstein	goldstein	O	O	O	O
and	and	O	O	O	O
Berkowitz	berkowitz	O	O	O	O
score	score	O	O	O	O
:	:	O	O	O	O
11	11	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
was	was	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
multiple	multiple	O	O	O	O
cytotoxic	cytotoxic	O	O	O	O
drugs	drugs	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
multiple	multiple	O	O	O	O
drug	drug	O	O	O	O
schema	schema	O	O	O	O
consisted	consisted	O	O	O	O
of	of	O	O	O	O
:	:	O	O	O	O
Etoposide	etoposide	CHEMICALS	O	OTHERS	I
16.213	16.213	O	O	O	O
,	,	O	O	O	O
Methotrexate	methotrexate	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
Cyclophosphamide	cyclophosphamide	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
Actomycin-D	actomycin-d	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
Cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

On	on	O	O	O	O
the	the	O	O	O	O
first	first	O	O	O	O
day	day	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
schedule	schedule	O	O	O	O
,	,	O	O	O	O
moderate	moderate	O	O	O	O
high	high	O	O	O	O
doses	doses	O	O	O	O
of	of	O	O	O	O
Methotrexate	methotrexate	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
Etoposide	etoposide	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
Cyclophosphamide	cyclophosphamide	CHEMICALS	O	OTHERS	I
were	were	O	O	O	O
administered	administered	O	O	O	O
.	.	O	O	O	O

Within	within	O	O	O	O
8	8	O	O	O	O
hours	hours	O	O	O	O
after	after	O	O	O	O
initiation	initiation	O	O	O	O
of	of	O	O	O	O
therapy	therapy	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
died	died	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
clinical	clinical	O	O	O	O
picture	picture	O	O	O	O
resembling	resembling	O	O	O	O
massive	massive	O	O	O	O
pulmonary	pulmonary	O	O	OTHERS	I
obstruction	obstruction	O	O	OTHERS	I
due	due	O	O	O	O
to	to	O	O	O	O
choriocarcinomic	choriocarcinomic	O	O	O	O
tissue	tissue	O	O	O	O
plugs	plugs	O	O	O	O
,	,	O	O	O	O
probably	probably	O	O	O	O
originating	originating	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
uterus	uterus	O	O	O	O
.	.	O	O	O	O

Formation	formation	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
plugs	plugs	O	O	O	O
was	was	O	O	O	O
probably	probably	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
extensive	extensive	O	O	O	O
tumor	tumor	O	DISEASE	OTHERS	I
necrosis	necrosis	O	DISEASE	OTHERS	I
at	at	O	O	O	O
the	the	O	O	O	O
level	level	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
walls	walls	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
major	major	O	O	O	O
uterine	uterine	O	O	O	O
veins	veins	O	O	O	O
,	,	O	O	O	O
which	which	O	O	O	O
resulted	resulted	O	O	O	O
in	in	O	O	O	O
an	an	O	O	O	O
open	open	O	O	O	O
exchange	exchange	O	O	O	O
of	of	O	O	O	O
tumor	tumor	O	DISEASE	OTHERS	I
plugs	plugs	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
vascular	vascular	O	O	O	O
spaces	spaces	O	O	O	O
;	;	O	O	O	O
decrease	decrease	O	O	O	O
in	in	O	O	O	O
tumor	tumor	O	DISEASE	OTHERS	I
tissue	tissue	O	O	O	O
coherence	coherence	O	O	O	O
secondary	secondary	O	O	O	O
to	to	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
may	may	O	O	O	O
have	have	O	O	O	O
further	further	O	O	O	O
contributed	contributed	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
formation	formation	O	O	O	O
of	of	O	O	O	O
tumor	tumor	O	DISEASE	OTHERS	I
emboli	emboli	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
view	view	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
close	close	O	O	O	O
time	time	O	O	O	O
association	association	O	O	O	O
between	between	O	O	O	O
the	the	O	O	O	O
start	start	O	O	O	O
of	of	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
acute	acute	O	O	O	O
onset	onset	O	O	O	O
of	of	O	O	O	O
massive	massive	O	O	O	O
embolism	embolism	O	O	OTHERS	I
other	other	O	O	O	O
explanations	explanations	O	O	O	O
,	,	O	O	O	O
such	such	O	O	O	O
as	as	O	O	O	O
spontaneous	spontaneous	O	O	O	O
necrosis	necrosis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
must	must	O	O	O	O
be	be	O	O	O	O
considered	considered	O	O	O	O
less	less	O	O	O	O
likely	likely	O	O	O	O
.	.	O	O	O	O

Patients	patients	O	O	O	O
with	with	O	O	O	O
large	large	O	O	O	O
pelvic	pelvic	O	O	OTHERS	I
tumor	tumor	O	DISEASE	OTHERS	I
loads	loads	O	O	O	O
are	are	O	O	O	O
,	,	O	O	O	O
according	according	O	O	O	O
to	to	O	O	O	O
existing	existing	O	O	O	O
classifications	classifications	O	O	O	O
,	,	O	O	O	O
at	at	O	O	O	O
high	high	O	O	O	O
risk	risk	O	O	O	O
to	to	O	O	O	O
die	die	O	O	O	O
and	and	O	O	O	O
to	to	O	O	O	O
develop	develop	O	O	O	O
drug	drug	O	O	O	O
resistance	resistance	O	O	O	O
.	.	O	O	O	O

Notwithstanding	notwithstanding	O	O	O	O
these	these	O	O	O	O
facts	facts	O	O	O	O
our	our	O	O	O	O
findings	findings	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
these	these	O	O	O	O
patients	patients	O	O	O	O
might	might	O	O	O	O
benefit	benefit	O	O	O	O
from	from	O	O	O	O
relatively	relatively	O	O	O	O
mild	mild	O	O	O	O
initial	initial	O	O	O	O
treatment	treatment	O	O	O	O
,	,	O	O	O	O
especially	especially	O	O	O	O
true	true	O	O	O	O
for	for	O	O	O	O
patients	patients	O	O	O	O
not	not	O	O	O	O
previously	previously	O	O	O	O
exposed	exposed	O	O	O	O
to	to	O	O	O	O
this	this	O	O	O	O
drug	drug	O	O	O	O
.	.	O	O	O	O

Close	close	O	O	O	O
observation	observation	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
response	response	O	O	O	O
status	status	O	O	O	O
both	both	O	O	O	O
clinically	clinically	O	O	O	O
and	and	O	O	O	O
with	with	O	O	O	O
beta-hCG	beta-hcg	O	O	O	O
values	values	O	O	O	O
may	may	O	O	O	O
indicate	indicate	O	O	O	O
whether	whether	O	O	O	O
and	and	O	O	O	O
when	when	O	O	O	O
more	more	O	O	O	O
agressive	agressive	O	O	O	O
combination	combination	O	O	O	O
chemotherapy	chemotherapy	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
started.(ABSTRACT	started.(abstract	O	O	O	O
TRUNCATED	truncated	O	O	O	O
AT	at	O	O	O	O
250	250	O	O	O	O
WORDS	words	O	O	O	O
)	)	O	O	O	O

